Cullinan Therapeutics (NASDAQ:CGEM) Reaches New 12-Month High – Time to Buy?
Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) reached a new 52-week high during trading on Tuesday . The stock traded as high as $13.43 and last traded at $13.3330, with a volume of 358294 shares. The stock had previously closed at $12.71. Analysts Set New Price Targets Several equities analysts recently commented […]
3 Feb 15:14 · The Cerbat Gem